Scarica l'app Stockscreener
9.56
12.21%
1.04
Dopo l'orario di chiusura:
9.58
0.02
+0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFMD Giù?
Forum
Previsione
Frazionamento azionario
Lifemd Inc Borsa (LFMD) Ultime notizie
LifeMD to Participate in Three Investor Conferences During May - The Manila Times
LifeMD, Inc. to Participate in Upcoming Investor Conferences in May 2025 - Nasdaq
LifeMD raises 2025 revenue guidance to $275M driven by telehealth growth - MSN
LFMD Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds LifeMD, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm - ACCESS Newswire
LifeMD Might Run Higher (NASDAQ:LFMD) - Seeking Alpha
LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st
Trading (LFMD) With Integrated Risk Controls - news.stocktradersdaily.com
(LFMDP) Investment Report - news.stocktradersdaily.com
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 By Investing.com - Investing.com Nigeria
LifeMD’s Earnings Call: Positive Growth and Strategic Expansion - TipRanks
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 - Investing.com Australia
BTIG maintains Buy rating, $12 target on LifeMD shares By Investing.com - Investing.com Nigeria
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story - simplywall.st
LifeMD, Inc. (NASDAQ:LFMD) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG maintains Buy rating, $12 target on LifeMD shares - Investing.com
LifeMD (LFMD) Exceeds Q1 Expectations and Raises 2025 Outlook - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD earnings beat by $0.07, revenue topped estimates - Investing.com Canada
LifeMD Inc (LFMD) Q1 2025 Earnings Call Highlights: Strong Telehealth Growth and Strategic Partnerships Propel Financial Success - GuruFocus
LifeMD (LFMD) Reports Strong Q1 2025 Performance and Raises Guid - GuruFocus
LifeMD Inc Reports Q1 2025 Earnings: EPS of $0.01 Beats Estimates, Revenue Surges to $65.7 Million - GuruFocus
LifeMD Inc reports results for the quarter ended March 31Earnings Summary - TradingView
LifeMD (LFMD) Sees High Call Activity Ahead of Earnings | LFMD S - GuruFocus
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: LifeMD Q1 2025 earnings beat expectations, stock rises - Investing.com
LifeMD (LFMD) Boosts FY25 Revenue and EBITDA Forecasts | LFMD Stock News - GuruFocus
LifeMD (LFMD) Surpasses Revenue Expectations with Strong Q1 Performance | LFMD Stock News - GuruFocus
LifeMD, Inc. SEC 10-Q Report - TradingView
LifeMD, Inc. Reports 49% Revenue Growth and First-Ever Positive GAAP EPS in Q1 2025 Financial Results - Nasdaq
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance - GlobeNewswire
LifeMD Crushes Q1 Expectations: 70% Telehealth Surge and Historic Profit Milestone - Stock Titan
LifeMD, Inc. Reports Strong Q1 2025 Results - TipRanks
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expec - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Have LifeMD Insiders Been Selling Stock? - simplywall.st
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators - MSN
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD (LFMD) to Announce Q1 2025 Earnings and Host Conference C - GuruFocus
LifeMD (LFMD) Enhances Access to Wegovy with NovoCare Partnershi - GuruFocus
LifeMD (LFMD) Forecasts Robust Earnings Growth Amid Expansion - GuruFocus
Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy - eMarketer
LifeMD expands access to weight management drug Wegovy - Investing.com
Why Hims & Hers Health and LifeMD Are Skyrocketing Today - Mitrade
Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy - MSN
LifeMD Stock Pops As Company Expands Weight-Loss Offerings With Wegovy - Benzinga
Wegovy to be sold on Hims, Ro and LifeMD for reduced price - Yahoo
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk’s Plan To Sell Wegovy Via Telehealth Operators By Stocktwits - Investing.com India
LifeMD and Hims & Hers Health shares surge on Novo Nordisk partnerships - Investing.com
LifeMD (LFMD) Expands Access to Wegovy with NovoCare Partnership - GuruFocus
LifeMD Expands Access to Weight-Loss Drug Wegovy; Shares Surge - marketscreener.com
LifeMD Shares Surge on Expanded Access to Wegovy - MarketWatch
LifeMD Announces Plans to Expand Affordable Access to Wegovy® fo - GuruFocus
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients - The Manila Times
0.67%
3.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):